disulfiram has been researched along with carfilzomib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Hasinoff, BB; Patel, D | 1 |
2 other study(ies) available for disulfiram and carfilzomib
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Disulfiram is a slow-binding partial noncompetitive inhibitor of 20S proteasome activity.
Topics: Acetaldehyde Dehydrogenase Inhibitors; Antineoplastic Agents; Bortezomib; Cell-Free System; Disulfiram; Humans; Kinetics; Oligopeptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Binding | 2017 |